Pharmaceutical Executive August 27, 2025
Key Takeaways
- Rapid innovation in oncology necessitates ensuring new therapies reach community oncologists, where most patients are treated.
- Addressing community oncology barriers involves enhancing medical affairs, simplifying diagnostics, and supporting insurance approvals.
- Precision medicine, through genomic profiling and adaptive trials, improves access and efficacy, crucial for complex therapies like CAR-T.
- Overcoming CAR-T challenges in solid tumors requires tackling scientific, operational, and economic barriers, with precision medicine playing a key role.
Putnam’s CEO discusses advancements in oncology and how companies are working to ensure patients have access to these new treatments.
Market access is one of the key issues for the pharmaceutical industry. It’s important to innovate, but it’s significantly more important to make sure that those innovations make...
Today's Sponsors
Today's Sponsor